FDA Drug Application (022023) for EMEND by MERCK AND CO INC

Back to FDA Applications sponsored by MERCK AND CO INC

Application Number022023
Product Number001
FormPOWDER;INTRAVENOUS
DosageEQ 115MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameEMEND
Active IngredientFOSAPREPITANT DIMEGLUMINE



Back to FDA Applications sponsored by MERCK AND CO INC

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.